Add Company
Join Now

OrsoBio Revenue and Competitors

License our Company Data API

Location

#7719

Growjo Ranking

Biotech

Industry
Embed

Estimated Revenue & Valuation

  • OrsoBio's estimated annual revenue is currently $2.2M per year.(i)
  • OrsoBio's estimated revenue per employee is $94,348
  • OrsoBio's total funding is $167M.

Employee Data

  • OrsoBio has 23 Employees.(i)
  • OrsoBio grew their employee count by 44% last year.

OrsoBio's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Chief Medical Officer and Head DevelopmentReveal Email/Phone
3
Chief Medical Officer and Head DevelopmentReveal Email/Phone
4
VP, Clinical Development & OperationsReveal Email/Phone
5
VP Product Development and Program ManagementReveal Email/Phone
6
Director, Regulatory AffairsReveal Email/Phone
7
ScientistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.4M70-8%$53MN/A
#2
$32.4M167-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.8M1813%N/AN/A
#5
$0.8M5-50%N/AN/A
#6
$0.8M100%N/AN/A
#7
$14M90-12%N/AN/A
#8
$0.4M33610%$236.7MN/A
#9
$4.8M62-74%$160MN/A
#10
$3.7M24-8%N/AN/A
Add Company

What Is OrsoBio?

OrsoBio, Inc. is a privately held, clinical-stage biopharmaceutical company dedicated to developing therapies to treat severe metabolic disorders, including type 2 diabetes, severe dyslipidemias, lipodystrophies, and nonalcoholic steatohepatitis. OrsoBio currently has four programs in clinical and preclinical development with first-in-class compounds that address central pathways in energy metabolism.

keywords:N/A

$167M

Total Funding

23

Number of Employees

$2.2M

Revenue (est)

44%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.9M2328%N/A
#2
$2.1M230%N/A
#3
$3.5M23-8%N/A
#4
$3.7M23109%$28M
#5
$7.5M23-4%N/A